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Summary. The cornified cell envelope (CE) is a tough 
structure formed beneath the plasma membrane of 
terminally differentiated keratinocytes. Recent progress 
in understanding the molecular organization of the CE 
has disclosed the complex, yet orderly structure that 
functions as a protective barrier against the environment. 
We have recently demonstrated that two inherited skin 
diseases, Vohwinkel's syndrome (VS) and progressive 
symmetric erythrokeratoderma (PSEK) may result from 
mutations in the gene encoding loricrin, a major 
constituent of the CE. In adult human epidermis, loricrin 
is diffusely distributed within the superficial granular 
cells. In the cornified cells, loricrin is associated with 
CEs. In some patients with VS and PSEK skin, however, 
granular cells contain many intranuclear granules which 
are labeled with an amino-terminal loricrin antibody. 
CEs are thinner than normal and sparsely labeled with 
the loricrin antibody. Parakeratotic cornified cells 
contain loricrin-positive granules. Sequencing of the 
loricrin gene has disclosed heterozygous mutations; 
insertion of one nucleotide (730insG, 709insC) that 
shifts the reading frame in these patients. Consequently 
the carboxyl-terminus are replaced by highly charged 
missense sequences that override the endogeneous 
termination codon extending the protein with an 
additional 22 amino acids. Elucidation of the molecular 
biology of "loricrin keratodermas" adds to our 
understanding of the complexity and biological 
significance of the CE. 
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Introduction 
A hallmark of terminally differentiated or cornified 
epidermal keratinocytes is the formation of a cornified 
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cell envelope (CE) (Hohl, 1990; Polakowska and 
Goldsmith, 1991; Reichert et al., 1993; Simon, 1994; 
Eckert et al., 1997; Ishida-Yamamoto and Iizuka, 1998). 
The CE is a continuous structure, 15- to 20-nm in 
thickness, formed beneath the plasma membrane (Brody, 
1969). It constitutes the most insoluble structure of 
stratified squamous epithelia and provides the tissue 
with a protective barrier against the environment. The 
CE  is composed of several molecules, including 
involucrin, cystatin A, elafin, loricrin and SPRRs. These 
molecules are cross-linked with NE-(y-glutamyl) lysine 
isopeptide bonds via the action of transglutaminases 1 
and 3. 
Although the composition of the constituent proteins 
of CE varies in different epithelia, loricrin (in latin, 
lorica stands for protective cuirasse of leather and metal) 
is most abundant in the epidermal CE (Steven and 
Steinert, 1994; Steinert, 1995). The physiological and 
pathological significance of loricrin has been high- 
lighted by recent discoveries of mutations in the loricrin 
gene in two inherited skin disorders, Vohwinkel's 
syndrome (VS) and progressive symmetric erythro- 
keratoderma (PSEK) (Maestrini et al., 1996; Ishida- 
Yamamoto et al., 1997; Korge et al., 1997). This article 
reviews the current understanding of the loricrin 
molecule and its gene,  and details the clinico- 
pathological findings and molecular genetic basis of the 
inherited diseases of loricrin. 
Loricrin is a unique structural protein 
Loricrin is a glycine-, serine- and cysteine-rich 
protein (Fig. 1) (Mehrel et al., 1990; Hohl et al., 1991b; 
Yoneda et al., 1992a). It  is highly insoluble perhaps 
because of the high glycine-content and intra-molecular 
disulfide bonds. The human loricrin protein is 26 kDa, 
consisting of 315 amino acid residues with a calculated 
p1 of 12 (Hohl et al., 1991b). In contrast, mouse loricrin 
is  3 8  kDa, contains 480 amino acids and has an 
estimated p1 of 9.5 (Mehrel et al., 1990). 
Loricrin contains many tandem quasi-repeats of a 
unique, highly flexible structure called a "glycine loop". 
Its general structure is represented as X(Y)n where X 
refers to aromatic or aliphatic amino acids, Y is glycine, 







